Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses
Research and development	$ 10,306,000	$ 2,848,000
General and administrative	6,704,000	965,000
Total operating expenses	17,010,000	3,813,000
Loss from operations	(17,010,000)	(3,813,000)
Other income (expense)
Currency exchange gain (loss), net	(20,000)	137,000
Interest income	15,000
Interest expense	(123,000)	(72,000)
Total other income (expense), net	(128,000)	65,000
Loss before income tax expense	(17,138,000)	(3,748,000)
Income tax expense	66,000	0
Net loss	(17,204,000)	(3,748,000)
Cumulative dividends on class B and C preference shares		(1,839,000)
Net loss attributable to common shareholders	$ (17,204,000)	$ (5,587,000)
Net loss per common share, basic and diluted	$ (0.60)	$ (31.53)
Weighted-average number of shares used in computing net loss per common share, basic and diluted	28,815,267	177,200
Other comprehensive loss
Net loss	$ (17,204,000)	$ (3,748,000)
Foreign currency translation	(2,647,000)	(1,766,000)
Total comprehensive loss	$ (19,851,000)	$ (5,514,000)